The global antimicrobial susceptibility testing market size is expected to reach USD 6.08 Billion at a steady revenue CAGR of 5.5% in 2032, according to latest analysis by Emergen Research. Antimicrobial susceptibility testing market revenue growth is expected to be driven by need for newer and more effective drugs due to rising multi-drug resistance in individuals. Antimicrobial Resistance (AMR) is a major threat to world health in the 21st century and calls for immediate action, according to the WHO. Drug-resistant illnesses already claim the lives of over 700,000 individuals annually, and by 2050, that number is expected to increase to 10 million. Correct treatment of patients against infections requires the use of Antibiotic Susceptibility Testing (AST), which establishes effective antibiotic doses and creates a profile of empirical therapy.
https://www.emergenresearch.com/request-sample/381
